Company Filing History:
Years Active: 2016-2017
Title: Innovative Contributions of Inventor Sunny Lim
Introduction
Sunny Lim is a distinguished inventor based in Gyeonggi-do, South Korea. With a notable portfolio consisting of two patents, he has made significant strides in the field of biomedicine, particularly through the development of macromolecule transduction domains.
Latest Patents
Sunny Lim's most recent patents include the development of a novel macromolecule transduction domain with improved cell permeability. This invention pertains to an enhanced MTD that facilitates the penetration of cell membranes by biologically active molecules more efficiently than existing methods. The MTD is designed to transmit various biologically active molecules effectively, whether within the human body or in laboratory settings. It holds promise in applications such as genetically altering biologically active molecules for cellular permeability and transporting such molecules into cells. The improved MTD can significantly impact drug delivery systems, recombinant protein vaccines, DNA/RNA therapeutic agents, and various therapies involving genes or proteins.
Career Highlights
Sunny Lim is currently associated with Procell Therapeutics Inc., where he continues to advance his research and innovations. His contributions to biomedicine are expected to pave the way for new drug development and improvements in therapeutic applications.
Collaborations
Throughout his career, Sunny has collaborated with esteemed colleagues such as Ki Deok Shin and Kang Jin Lee. His partnerships within the research community have been instrumental in advancing his inventive pursuits and fostering innovation within the field.
Conclusion
Sunny Lim is making a significant impact in the realm of biologically active molecule research through his inventions and collaborative efforts. His developments in macromolecule transduction domains are poised to lead to breakthroughs in drug delivery and therapeutic advancements, showcasing the vital role of inventors in transforming health sciences.